VT
GMAB icon

Vise Technologies’s Genmab GMAB Stock Holding History

Vise Technologies’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$450K Sell
16,377
-167
-1% -$4.44K 0.01% 1218
2026
Q1 		$510K Hold
16,544
– – 0.01% 856
2025
Q4 		$510K Buy
16,544
+2,656
+19% +$82.8K 0.01% 861
2025
Q3 		$426K Sell
13,888
-570
-4% -$13.9K 0.02% 739
2025
Q2 		$299K Buy
+14,458
New +$297K 0.01% 840
2024
Q4 		$269K Buy
12,892
+3,794
+42% +$83.4K 0.02% 641
2024
Q3 		$222K Buy
+9,098
New +$243K 0.03% 543

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vise Technologies's GMAB Position: Q2 2026 in Review

Vise Technologies reduced its Genmab (GMAB) stake by 1% in Q2 2026, selling an estimated $4.44K and leaving 16,377 shares worth $450K. The position accounts for 0.01% of the portfolio, ranked #1218.

Vise Technologies first reported a position in GMAB in Q3 2024 and has held it in 7 quarters since. The position peaked at $510K in Q1 2026. 291 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Vise Technologies held 16,377 shares of Genmab worth $450K as of Q2 2026.
  • Vise Technologies sold 167 Genmab shares in Q2 2026, an estimated $4.44K.
  • Genmab made up 0.01% of Vise Technologies's portfolio in Q2 2026, its #1218 holding.
  • Vise Technologies first reported a position in Genmab in Q3 2024 and has held it in 7 quarters since.
  • Vise Technologies's Genmab position peaked at $510K in Q1 2026.
  • 291 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.